结直肠癌筛查
Colorectal cancer screening.
作者信息
McLoughlin Ramona-M, O'Morain Colm-A
出版信息
World J Gastroenterol. 2006 Nov 14;12(42):6747-50. doi: 10.3748/wjg.v12.i42.6747.
Abstract
Colorectal cancer is a major public health burden worldwide. There is clear-cut evidence that screening will reduce colorectal cancer mortality and the only contentious issue is which screening tool to use. Most evidence points towards screening with fecal occult blood testing. The immunochemical fecal occult blood tests have a higher sensitivity than the guaiac-based tests. In addition, their automation and haemoglobin quantification allows a threshold for colonoscopy to be selected that can be accommodated within individual health care systems.
摘要
结直肠癌是全球主要的公共卫生负担。有明确证据表明筛查可降低结直肠癌死亡率，唯一有争议的问题是使用哪种筛查工具。大多数证据指向采用粪便潜血检测进行筛查。免疫化学粪便潜血检测比基于愈创木脂的检测具有更高的灵敏度。此外，其自动化和血红蛋白定量功能使得能够选择一个适合个体医疗保健系统的结肠镜检查阈值。
相似文献
1
Colorectal cancer screening.结直肠癌筛查
World J Gastroenterol. 2006 Nov 14;12(42):6747-50. doi: 10.3748/wjg.v12.i42.6747.
2
From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening.从愈创木脂法到免疫粪便潜血检测：结直肠癌筛查技术的兴起
Gastroenterol Nurs. 2005 Mar-Apr;28(2):90-6. doi: 10.1097/00001610-200503000-00002.
3
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.使用新型粪便潜血试验筛查结直肠肿瘤：性能特征的最新进展。
J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. doi: 10.1093/jnci/djm150. Epub 2007 Sep 25.
4
Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.在一项 2235 名筛查结肠镜参与者的头对头比较中，粪便免疫化学试验检测血红蛋白的诊断性能优于愈创木脂粪便隐血试验。
Eur J Cancer. 2013 Sep;49(14):3049-54. doi: 10.1016/j.ejca.2013.04.023. Epub 2013 May 22.
5
Which colorectal cancer screening test is best?哪种结直肠癌筛查测试最好？
J Natl Cancer Inst. 2007 Oct 3;99(19):1424-5. doi: 10.1093/jnci/djm166. Epub 2007 Sep 25.
6
Colorectal cancer screening: scientific review.结直肠癌筛查：科学综述
JAMA. 2003 Mar 12;289(10):1288-96. doi: 10.1001/jama.289.10.1288.
7
Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.综合医疗诊所中的粪便潜血检测：基于愈创木脂法和基于免疫化学法检测的比较
Am J Med. 2003 Aug 1;115(2):111-4. doi: 10.1016/s0002-9343(03)00294-8.
8
Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.在一项针对结直肠癌筛查计划中，对粪便隐血试验呈阳性的个体进行免疫化学检测：一项观察性研究。
Lancet Oncol. 2006 Feb;7(2):127-31. doi: 10.1016/S1470-2045(05)70473-3.
9
Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.粪便免疫化学试验与愈创木脂粪便潜血试验：临床医生和结直肠癌筛查计划组织者需要了解的内容。
Gut. 2015 Aug;64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3.
10
The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.退伍军人事务部为患者提供的筛查结肠镜检查服务。
Arch Intern Med. 2006 Nov 13;166(20):2202-8. doi: 10.1001/archinte.166.20.2202.
引用本文的文献
1
Utility of FDG PET/CT in Patient with Synchronous Breast and Colon Cancer.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG PET/CT）在同时性乳腺癌和结肠癌患者中的应用价值
Diagnostics (Basel). 2023 Jul 6;13(13):2293. doi: 10.3390/diagnostics13132293.
2
Quantification of mitochondrial cfDNA reveals new perspectives for early diagnosis of colorectal cancer.线粒体 cfDNA 定量分析为结直肠癌的早期诊断提供了新视角。
BMC Cancer. 2023 Mar 30;23(1):291. doi: 10.1186/s12885-023-10748-y.
3
Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review.循环肿瘤DNA分析：对结直肠癌患者的临床意义。一项系统综述。
JNCI Cancer Spectr. 2019 Jun 19;3(3):pkz042. doi: 10.1093/jncics/pkz042. eCollection 2019 Sep.
4
FICE in Predicting Colorectal Flat Lesion Histology.窄带成像技术在预测结直肠扁平病变组织学方面的应用
JSLS. 2017 Oct-Dec;21(4). doi: 10.4293/JSLS.2017.00050.
5
The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings.医院环境中粪便潜血试验检测结直肠癌的敏感性、特异性、预测值和似然比。
Clin Exp Gastroenterol. 2015 Sep 9;8:279-84. doi: 10.2147/CEG.S86419. eCollection 2015.
6
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer.循环 miR-378 在血浆中：一种可靠的、与溶血无关的结直肠癌生物标志物。
Br J Cancer. 2014 Feb 18;110(4):1001-7. doi: 10.1038/bjc.2013.819. Epub 2014 Jan 14.
7
Factors influencing quality of bowel preparation for colonoscopy.影响结肠镜检查肠道准备质量的因素。
World J Gastrointest Endosc. 2013 Feb 16;5(2):39-46. doi: 10.4253/wjge.v5.i2.39.
8
Use of colon cancer testing in rural Colorado primary care practices.科罗拉多农村初级保健实践中结肠癌检测的应用。
J Gen Intern Med. 2009 Oct;24(10):1095-100. doi: 10.1007/s11606-009-1063-0. Epub 2009 Aug 27.
9
Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.粪便DNA中高甲基化的SFRP2基因是用于结直肠癌无创筛查的一种极具潜力的生物标志物。
World J Gastroenterol. 2008 Jan 28;14(4):524-31. doi: 10.3748/wjg.14.524.
10
Usefulness of fecal lactoferrin and hemoglobin in diagnosis of colorectal diseases.粪便乳铁蛋白和血红蛋白在结直肠疾病诊断中的应用价值。
World J Gastroenterol. 2007 Mar 14;13(10):1569-74. doi: 10.3748/wjg.v13.i10.1569.
本文引用的文献
1
Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.一种自动开发的定量免疫化学粪便潜血筛查试验的性能特征与评估
Am J Gastroenterol. 2005 Nov;100(11):2519-25. doi: 10.1111/j.1572-0241.2005.00231.x.
2
A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.无症状人群中免疫化学粪便潜血试验与全结肠镜检查的比较。
Gastroenterology. 2005 Aug;129(2):422-8. doi: 10.1016/j.gastro.2005.05.056.
3
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.PLCO癌症筛查试验中的乙状结肠镜检查：一项随机试验基线筛查检查的结果
J Natl Cancer Inst. 2005 Jul 6;97(13):989-97. doi: 10.1093/jnci/dji175.
4
Colonoscopic screening of average-risk women for colorectal neoplasia.对平均风险女性进行结肠镜检查以筛查结直肠肿瘤。
N Engl J Med. 2005 May 19;352(20):2061-8. doi: 10.1056/NEJMoa042990.
5
Colon cancer screening in 2005: status and challenges.2005年的结肠癌筛查：现状与挑战。
Gastroenterology. 2005 May;128(6):1685-95. doi: 10.1053/j.gastro.2005.04.005.
6
Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial.饮食性息肉预防试验中监测结肠镜检查期间结直肠癌发生情况的分析。
Gastrointest Endosc. 2005 Mar;61(3):385-91. doi: 10.1016/s0016-5107(04)02765-8.
7
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.平均风险人群中粪便DNA与粪便潜血用于结直肠癌筛查的比较
N Engl J Med. 2004 Dec 23;351(26):2704-14. doi: 10.1056/NEJMoa033403.
8
Evaluation of polyp detection in relation to procedure time of screening or surveillance colonoscopy.评估息肉检测与筛查或监测结肠镜检查操作时间的关系。
Am J Gastroenterol. 2004 Oct;99(10):1941-5. doi: 10.1111/j.1572-0241.2004.40569.x.
9
Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).挪威结直肠癌预防试验中关于乙状结肠镜筛查的粪便钙卫蛋白（PhiCal）检测：与潜血免疫化学检测（FlexSure OBT）的比较
Gut. 2004 Sep;53(9):1329-33. doi: 10.1136/gut.2004.039032.
10
Reasons for failure to diagnose colorectal carcinoma at colonoscopy.结肠镜检查时未能诊断出结直肠癌的原因。
Endoscopy. 2004 Jun;36(6):499-503. doi: 10.1055/s-2004-814399.
Zotero 插件